Cart
sales@molnova.com
Tirzepatide
CAS No. 2023788-19-2
Tirzepatide( LY3298176 )
Catalog No. M29810 CAS No. 2023788-19-2
Tirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 628 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameTirzepatide
-
NoteResearch use only, not for human use.
-
Brief DescriptionTirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).
-
DescriptionTirzepatide (TZP), a novel dual GIP and GLP-1 receptor agonist (RA).(In Vivo):Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.
-
In Vitro——
-
In VivoTirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.
-
SynonymsLY3298176
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2023788-19-2
-
Formula Weight4813.45
-
Molecular FormulaC225H348N48O68
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (10.39 mM)
-
SMILES——
-
Chemical NameSequence:Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Frias JP, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet. 2018 Nov 17;392(10160):2180-2193.
molnova catalog
related products
-
GLP-2(1-33)(human)
GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium.
-
Survodutide
Survodutide (BI 456906) is a dual agonist of glucagon and glucagon-like peptide 1 (GLP-1) receptors (GLP Receptor) that reduces body weight in HbA1c16 diabetes.
-
LGD-6972
LGD-6972 (RVT 1502) is a novel potent, selective, orally bioavailable glucagon receptor (GCGR) antagonist.
